List of Tables
Table 1. Global Vancomycin Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Vancomycin Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Vancomycin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Vancomycin Sales (KG) of Key Manufacturers (2018-2023)
Table 5. Global Vancomycin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Vancomycin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Vancomycin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Vancomycin Average Price (US$/G) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Vancomycin, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Vancomycin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vancomycin, Product Type & Application
Table 12. Global Key Manufacturers of Vancomycin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vancomycin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vancomycin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vancomycin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Vancomycin Sales by Region (2018-2023) & (KG)
Table 18. Global Vancomycin Sales Market Share by Region (2018-2023)
Table 19. Global Vancomycin Sales by Region (2024-2029) & (KG)
Table 20. Global Vancomycin Sales Market Share by Region (2024-2029)
Table 21. Global Vancomycin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Vancomycin Revenue Market Share by Region (2018-2023)
Table 23. Global Vancomycin Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Vancomycin Revenue Market Share by Region (2024-2029)
Table 25. North America Vancomycin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Vancomycin Sales by Country (2018-2023) & (KG)
Table 27. North America Vancomycin Sales by Country (2024-2029) & (KG)
Table 28. North America Vancomycin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Vancomycin Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Vancomycin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Vancomycin Sales by Country (2018-2023) & (KG)
Table 32. Europe Vancomycin Sales by Country (2024-2029) & (KG)
Table 33. Europe Vancomycin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Vancomycin Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Vancomycin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Vancomycin Sales by Region (2018-2023) & (KG)
Table 37. Asia Pacific Vancomycin Sales by Region (2024-2029) & (KG)
Table 38. Asia Pacific Vancomycin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Vancomycin Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Vancomycin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Vancomycin Sales by Country (2018-2023) & (KG)
Table 42. Latin America Vancomycin Sales by Country (2024-2029) & (KG)
Table 43. Latin America Vancomycin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Vancomycin Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Vancomycin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Vancomycin Sales by Country (2018-2023) & (KG)
Table 47. Middle East & Africa Vancomycin Sales by Country (2024-2029) & (KG)
Table 48. Middle East & Africa Vancomycin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Vancomycin Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Vancomycin Sales (KG) by Type (2018-2023)
Table 51. Global Vancomycin Sales (KG) by Type (2024-2029)
Table 52. Global Vancomycin Sales Market Share by Type (2018-2023)
Table 53. Global Vancomycin Sales Market Share by Type (2024-2029)
Table 54. Global Vancomycin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Vancomycin Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Vancomycin Revenue Market Share by Type (2018-2023)
Table 57. Global Vancomycin Revenue Market Share by Type (2024-2029)
Table 58. Global Vancomycin Price (US$/G) by Type (2018-2023)
Table 59. Global Vancomycin Price (US$/G) by Type (2024-2029)
Table 60. Global Vancomycin Sales (KG) by Application (2018-2023)
Table 61. Global Vancomycin Sales (KG) by Application (2024-2029)
Table 62. Global Vancomycin Sales Market Share by Application (2018-2023)
Table 63. Global Vancomycin Sales Market Share by Application (2024-2029)
Table 64. Global Vancomycin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Vancomycin Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Vancomycin Revenue Market Share by Application (2018-2023)
Table 67. Global Vancomycin Revenue Market Share by Application (2024-2029)
Table 68. Global Vancomycin Price (US$/G) by Application (2018-2023)
Table 69. Global Vancomycin Price (US$/G) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 73. Pfizer Vancomycin Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Eli Lilly and Company Corporation Information
Table 76. Eli Lilly and Company Description and Business Overview
Table 77. Eli Lilly and Company Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 78. Eli Lilly and Company Vancomycin Product
Table 79. Eli Lilly and Company Recent Developments/Updates
Table 80. CJ CheilJedang Corporation Information
Table 81. CJ CheilJedang Description and Business Overview
Table 82. CJ CheilJedang Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 83. CJ CheilJedang Vancomycin Product
Table 84. CJ CheilJedang Recent Developments/Updates
Table 85. Xellia Pharmaceuticals ApS Corporation Information
Table 86. Xellia Pharmaceuticals ApS Description and Business Overview
Table 87. Xellia Pharmaceuticals ApS Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 88. Xellia Pharmaceuticals ApS Vancomycin Product
Table 89. Xellia Pharmaceuticals ApS Recent Developments/Updates
Table 90. VIANEX Corporation Information
Table 91. VIANEX Description and Business Overview
Table 92. VIANEX Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 93. VIANEX Vancomycin Product
Table 94. VIANEX Recent Developments/Updates
Table 95. Alchemia Limited Corporation Information
Table 96. Alchemia Limited Description and Business Overview
Table 97. Alchemia Limited Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 98. Alchemia Limited Vancomycin Product
Table 99. Alchemia Limited Recent Developments/Updates
Table 100. Alvogen Corporation Information
Table 101. Alvogen Description and Business Overview
Table 102. Alvogen Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 103. Alvogen Vancomycin Product
Table 104. Alvogen Recent Developments/Updates
Table 105. Aphios Corporation Corporation Information
Table 106. Aphios Corporation Description and Business Overview
Table 107. Aphios Corporation Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 108. Aphios Corporation Vancomycin Product
Table 109. Aphios Corporation Recent Developments/Updates
Table 110. Cellceutix Corporation Corporation Information
Table 111. Cellceutix Corporation Description and Business Overview
Table 112. Cellceutix Corporation Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 113. Cellceutix Corporation Vancomycin Product
Table 114. Cellceutix Corporation Recent Developments/Updates
Table 115. Enanta Pharmaceuticals Corporation Information
Table 116. Enanta Pharmaceuticals Description and Business Overview
Table 117. Enanta Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 118. Enanta Pharmaceuticals Vancomycin Product
Table 119. Enanta Pharmaceuticals Recent Developments/Updates
Table 120. Helix BioMedix Corporation Information
Table 121. Helix BioMedix Description and Business Overview
Table 122. Helix BioMedix Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 123. Helix BioMedix Vancomycin Product
Table 124. Helix BioMedix Recent Developments/Updates
Table 125. LegoChem Biosciences Corporation Information
Table 126. LegoChem Biosciences Description and Business Overview
Table 127. LegoChem Biosciences Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 128. LegoChem Biosciences Vancomycin Product
Table 129. LegoChem Biosciences Recent Developments/Updates
Table 130. Lytix Biopharma Corporation Information
Table 131. Lytix Biopharma Description and Business Overview
Table 132. Lytix Biopharma Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 133. Lytix Biopharma Vancomycin Product
Table 134. Lytix Biopharma Recent Developments/Updates
Table 135. MGB Biopharma Limited Corporation Information
Table 136. MGB Biopharma Limited Description and Business Overview
Table 137. MGB Biopharma Limited Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 138. MGB Biopharma Limited Vancomycin Product
Table 139. MGB Biopharma Limited Recent Developments/Updates
Table 140. Microbiotix. Corporation Information
Table 141. Microbiotix. Description and Business Overview
Table 142. Microbiotix. Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 143. Microbiotix. Vancomycin Product
Table 144. Microbiotix. Recent Developments/Updates
Table 145. MicuRx Pharmaceuticals Corporation Information
Table 146. MicuRx Pharmaceuticals Description and Business Overview
Table 147. MicuRx Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 148. MicuRx Pharmaceuticals Vancomycin Product
Table 149. MicuRx Pharmaceuticals Recent Developments/Updates
Table 150. Nabriva Therapeutics Corporation Information
Table 151. Nabriva Therapeutics Description and Business Overview
Table 152. Nabriva Therapeutics Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 153. Nabriva Therapeutics Vancomycin Product
Table 154. Nabriva Therapeutics Recent Developments/Updates
Table 155. NovaBay Pharmaceuticals Corporation Information
Table 156. NovaBay Pharmaceuticals Description and Business Overview
Table 157. NovaBay Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 158. NovaBay Pharmaceuticals Vancomycin Product
Table 159. NovaBay Pharmaceuticals Recent Developments/Updates
Table 160. NovoBiotic Pharmaceuticals Corporation Information
Table 161. NovoBiotic Pharmaceuticals Description and Business Overview
Table 162. NovoBiotic Pharmaceuticals Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 163. NovoBiotic Pharmaceuticals Vancomycin Product
Table 164. NovoBiotic Pharmaceuticals Recent Developments/Updates
Table 165. Oragenics Corporation Information
Table 166. Oragenics Description and Business Overview
Table 167. Oragenics Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 168. Oragenics Vancomycin Product
Table 169. Oragenics Recent Developments/Updates
Table 170. Sealife Pharma Corporation Information
Table 171. Sealife Pharma Description and Business Overview
Table 172. Sealife Pharma Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 173. Sealife Pharma Vancomycin Product
Table 174. Sealife Pharma Recent Developments/Updates
Table 175. Taiwan Zhengde Pharmaceutical Corporation Information
Table 176. Taiwan Zhengde Pharmaceutical Description and Business Overview
Table 177. Taiwan Zhengde Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 178. Taiwan Zhengde Pharmaceutical Vancomycin Product
Table 179. Taiwan Zhengde Pharmaceutical Recent Developments/Updates
Table 180. Zhejiang Pharmaceutical Corporation Information
Table 181. Zhejiang Pharmaceutical Description and Business Overview
Table 182. Zhejiang Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 183. Zhejiang Pharmaceutical Vancomycin Product
Table 184. Zhejiang Pharmaceutical Recent Developments/Updates
Table 185. Zhejiang Haizheng Pharmaceutical Corporation Information
Table 186. Zhejiang Haizheng Pharmaceutical Description and Business Overview
Table 187. Zhejiang Haizheng Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 188. Zhejiang Haizheng Pharmaceutical Vancomycin Product
Table 189. Zhejiang Haizheng Pharmaceutical Recent Developments/Updates
Table 190. North China Pharmaceutical Corporation Information
Table 191. North China Pharmaceutical Description and Business Overview
Table 192. North China Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 193. North China Pharmaceutical Vancomycin Product
Table 194. North China Pharmaceutical Recent Developments/Updates
Table 195. Shenwei Pharmaceutical Corporation Information
Table 196. Shenwei Pharmaceutical Description and Business Overview
Table 197. Shenwei Pharmaceutical Vancomycin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2018-2023)
Table 198. Shenwei Pharmaceutical Vancomycin Product
Table 199. Shenwei Pharmaceutical Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Vancomycin Distributors List
Table 203. Vancomycin Customers List
Table 204. Vancomycin Market Trends
Table 205. Vancomycin Market Drivers
Table 206. Vancomycin Market Challenges
Table 207. Vancomycin Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vancomycin
Figure 2. Global Vancomycin Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Vancomycin Market Share by Type in 2022 & 2029
Figure 4. Daptomycin Product Picture
Figure 5. Linezolid Product Picture
Figure 6. Quinupristin Product Picture
Figure 7. Ampicillin Product Picture
Figure 8. Chloramphenicol Product Picture
Figure 9. Others Product Picture
Figure 10. Global Vancomycin Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Vancomycin Market Share by Application in 2022 & 2029
Figure 12. Sepsis
Figure 13. Lung Infection
Figure 14. Skin Soft Tissue Infection
Figure 15. Colitis & Intestinal Inflammation
Figure 16. To Prevent Infection
Figure 17. Global Vancomycin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Vancomycin Market Size (2018-2029) & (US$ Million)
Figure 19. Global Vancomycin Sales (2018-2029) & (KG)
Figure 20. Global Vancomycin Average Price (US$/G) & (2018-2029)
Figure 21. Vancomycin Report Years Considered
Figure 22. Vancomycin Sales Share by Manufacturers in 2022
Figure 23. Global Vancomycin Revenue Share by Manufacturers in 2022
Figure 24. The Global 5 and 10 Largest Vancomycin Players: Market Share by Revenue in 2022
Figure 25. Vancomycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 26. Global Vancomycin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 27. North America Vancomycin Sales Market Share by Country (2018-2029)
Figure 28. North America Vancomycin Revenue Market Share by Country (2018-2029)
Figure 29. U.S. Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Canada Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Europe Vancomycin Sales Market Share by Country (2018-2029)
Figure 32. Europe Vancomycin Revenue Market Share by Country (2018-2029)
Figure 33. Germany Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Vancomycin Sales Market Share by Region (2018-2029)
Figure 39. Asia Pacific Vancomycin Revenue Market Share by Region (2018-2029)
Figure 40. China Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Japan Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. South Korea Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. India Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Australia Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Taiwan Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Indonesia Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Thailand Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Malaysia Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Philippines Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Latin America Vancomycin Sales Market Share by Country (2018-2029)
Figure 51. Latin America Vancomycin Revenue Market Share by Country (2018-2029)
Figure 52. Mexico Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Brazil Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Argentina Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Middle East & Africa Vancomycin Sales Market Share by Country (2018-2029)
Figure 56. Middle East & Africa Vancomycin Revenue Market Share by Country (2018-2029)
Figure 57. Turkey Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. UAE Vancomycin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Global Sales Market Share of Vancomycin by Type (2018-2029)
Figure 61. Global Revenue Market Share of Vancomycin by Type (2018-2029)
Figure 62. Global Vancomycin Price (US$/G) by Type (2018-2029)
Figure 63. Global Sales Market Share of Vancomycin by Application (2018-2029)
Figure 64. Global Revenue Market Share of Vancomycin by Application (2018-2029)
Figure 65. Global Vancomycin Price (US$/G) by Application (2018-2029)
Figure 66. Vancomycin Value Chain
Figure 67. Vancomycin Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed